BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or BPC157 Dosing Recommendations by Weight TikTok BPC 157 ORAL Beverly Hills Rejuvenation Center BPC 157: What It Is, What We Know, and Why Its Use for Arthritis Remains Unproven San Diego Orthobiologics Medical Group Oral Peptides: FAQs on Bioavailability, Safety, and Clinical Use AJMC